Defibrillators Market | Key Players are Koninklijke Philips N.V., Metrax GmbH (Primedic), Mindray Medical International Limited, Medical Information Technology, Inc., ZOLL Medical Corporation, Philips Healthcare, and GE Healthcare.

The Defibrillators Market is expected to have a highly positive outlook for the next five years 2018 – 2026 according to a recently released Defibrillators Market research report. The report has been added in his large database by Coherent Market Insights.

The major takeaways in the report are product segment analysis, application segment analysis, regional segment analysis and data of the major Defibrillators Market players from around the world. The report presents an introductory as well as detailed information about the Defibrillators Market through a well-organized layout divided into easy to understand chapters.

Download PDF Brochure@ www.coherentmarketinsights.com/insight/request-pdf/115

Defibrillator is an essential tool in cardiopulmonary resuscitation indicated in cardiac arrhythmia. Various advancements have been observed in defibrillator technology – from manual to automated ones, and implantable defibrillators to ensure constant care for patients suffering from ischemic heart disease or those at high risk of cardiac arrest. A Global Resuscitation Alliance (GRA) was formed in 2016, comprising international health organizations, global resuscitation leaders, and the American Heart Association (AHA), with an objective to increase the survival rate of patients with sudden cardiac arrest, by 50%. This alliance actively works towards increasing public awareness about defibrillators and has facilitated the installation of automated defibrillators in public places for use in case of related medical emergencies. Training initiatives such as by-stander PCR training by manufacturers would considerably contribute towards improvement in survival rates, while enhancing brand visibility.

Defibrillators have improved significantly in terms of cost, size reduction and ease of operation. Two of the most important of these advancements are development of automated external defibrillator (AED) and implantable cardioverter defibrillator (ICD). These devices help prevent cardiac attacks, with little or no external assistance irrespective of the time and location in case of any major variations in heartbeat. However, cases of inappropriate functioning leading to hospitalization or even death of the patient has led to implementation of stringent regulations for approval and usage of the devices at potential patient sites. The U.S. FDA in 2015 issued an order to include pre-marketing approval (PMA) submission for all the prevalent and new defibrillators.

Some of the major manufacturers in the global defibrillators market include Koninklijke Philips N.V., Metrax GmbH (Primedic), Mindray Medical International Limited, Medical Information Technology, Inc., ZOLL Medical Corporation, Philips Healthcare, and GE Healthcare.

Detailed Segmentation:

Global Defibrillators Market, By Product Type:
Implantable Cardioverter Defibrillator
Single Chamber Implantable Cardioverter Defibrillator
Dual Chamber Implantable Cardioverter Defibrillator
External Defibrillator
Manual External Defibrillator
Automated External Defibrillator
Wearable Cardioverter Defibrillators
Global Defibrillators Market, By End User:
Hospitals
Public Access
Emergency Medical Services
Homecare Settings
Work Spaces

Request for Customization@ https://www.coherentmarketinsights.com/insight/request-customization/115

Technological advancements aiding to improve the defibrillators market dynamics

Defibrillators have improved significantly in terms of cost, size reduction and ease of operation. Two of the most important of these advancements are development of automated external defibrillator (AED) and implantable cardioverter defibrillator (ICD). These devices help prevent cardiac attacks, with little or no external assistance irrespective of the time and location in case of any major variations in heartbeat. However, cases of inappropriate functioning leading to hospitalization or even death of the patient has led to implementation of stringent regulations for approval and usage of the devices at potential patient sites. The U.S. FDA in 2015 issued an order to include pre-marketing approval (PMA) submission for all the prevalent and new defibrillators.

A research by Dr. Lee, at the University of California, San Francisco, found that 38% of shocks generated by implanted defibrillators are inappropriate. This is found to result in an increase in treatment cost by nearly US$ 4,500. Philips had to stop selling its defibrillator in 2016 due to supply chain and safety issues raised by the U.S. Justice Department.

With technological improvements, operating a defibrillator has become very easy for a by-stander post induction of proper training. Inbuilt audio and video support with combined CPR and defibrillator facility have encouraged people to use them at public places and at homes as well in turn posing a threat to advanced life support defibrillators (ALS).

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.